-
April - June 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
29 Aug 2025 20:22 GMT
… zirconium cyclosilicate)
Gastrointestinal disorders
FDA determined that no action … zoster.
Sarclisa labeling
Sprycel (dasatinib)
Drug-induced liver injury
The … about hepatotoxicity.
Sprycel labeling
Taxotere (docetaxel)
Rhabdomyolysis
FDA determined that …
-
Bristol Myers beats forecasts on strong drug sales
01 Aug 2025 17:16 GMT
… blood thinner Eliquis and cancer treatments Opdivo and Revlimid. Revenue in … very competitive pharmaceutical industry, where businesses must continuously replace outdated medications with … of its other cancer drugs, such as Pomalyst, Sprycel and Abraxane, are …
-
4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential
28 Jul 2025 19:37 GMT
… Pomalyst/Imnovid
Sprycel
Abraxane
Jefferies has a … that specializes in pharmaceuticals, biotechnology, and medical devices. With a … IVL) platform for the treatment of coronary artery disease …
The company offers medicines and vaccines in various therapeutic …
-
Fighting Financial Toxicity Through Oncology Drug Donation
28 Jul 2025 18:16 GMT
… treatment, the environmental and financial toll of unused medications … imatinib [Gleevec; Novartis Pharmaceuticals], dasatinib [Sprycel; Bristol Myers Squibb … doctor, who will direct them to dispose of the medications … . Temperature-sensitive drugs, for example, …
-
How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab
24 Jul 2025 12:19 GMT
… certain endpoints well before clinical trials.
Mike Ellis, SVP, … like Revlimid, Pomalyst and Sprycel in the coming years.
… and bypass the empirical trial and error process.”
Chemistry … joined a medicinal chemistry team within the pharmaceutical industry, we …
-
NCCN Flash Update: Updated CML Guidelines Emphasize Distress Screening, Drug Interactions, and Cost
18 Jul 2025 19:52 GMT
… dosing schedule, treatment goals, and medication cost—each now … essential thrombocythemia.
Updated Drug Interaction Tables and … as bosutinib, dasatinib (Sprycel; Bristol Myers Squibb), … ponatinib (Iclusig; Takeda Pharmaceuticals) includes a recommendation to …
-
Sprycel Market Report for M&A, Expansion, and Competitive Benchmarking (2025–2034)
18 Jun 2025 08:22 GMT
… oncology therapeutics, combination therapy trials, and sustainability in pharmaceutical manufacturing. Major trends … cancer treatments. The generic version of Sprycel refers to dasatinib-based medications produced …
-
Insurance denied Bucks County man cancer medication. Here's how he still got it
20 Jun 2025 11:15 GMT
… survival to the prescription medication Sprycel, which he says he … switching from a successful treatment posed too much risk. … Field recommends asking your doctor to write a letter … of medication from Bristol Myers Squibb at no cost.
Many pharmaceutical …
-
Liberia: Patients at CB Dunbar Hospital Praise Direct Relief for Free Lifesaving Drugs
13 Jun 2025 04:46 GMT
… currently receiving treatment at CB Dunbar Hospital using medications such as … Nilotinib (Tasigna), Dasatinib (Sprycel), and Bosutinib (Bosulif). These drugs, considered costly in … longer and better,” a medical doctor at the hospital told FrontPageAfrica …
-
Aurobindo’s Eugia Pharma Specialities obtains FDA OK for generic Sprycel
15 May 2025 20:49 GMT
… , has received the Food and Drug Administration’s permission to manufacture … .
The medication is the generic of Bristol-Myers Squibb’s Sprycel, which … FY26.
[Read more: Aurobindo obtains FDA OK for generic Keflet]
The …